Gene Synthesis Market Analysis 2018-2025: Thermo Fisher Scientific, Integrated DNA Technologies, Twist Bioscience, OriGene Technologies, BioCat, GenScript, Eurofins Scientific, Bioneer Corporation

The global gene synthesis market estimated to grow at a CAGR of 28.7% during the forecast period from 2018 to 2025. The gene synthesis market was valued at USD 2,866.1 Mn in 2017 and is estimated to reach US$ 20,122.3 Mn by 2025.

The increasing investments & funds, especially for the development of a new enzymatic approach to DNA synthesis is expected to propel the growth for the global gene synthesis market. The technology platform, and other related resources are helping the company to accelerate the development of the gene synthesis. Companies have also increased their research and development funds for the enhancement of the gene synthesis.

Get PDF sample copy: http://bit.ly/2X4Xqes

The major players operating in the gene synthesis market include Thermo Fisher Scientific Inc, Integrated DNA Technologies, Inc., Twist Bioscience, OriGene Technologies, Inc., BioCat GmbH, GenScript, Eurofins Scientific, Bioneer Corporation, ATUM, GENEWIZ and among others.

The global gene synthesis market is highly competitive and driven by large number of agreements, collaboration and partnerships. For instance, in July 2017 Twist Bioscience signed an agreement with Synbio Technologies. The aim of the agreement is to provide the next generation DNA manufacturing and long-length DNA assembly at a commercial scale to customers across the globe.

Growing clinical research is expected to drive the market for gene synthesis over the forecast period

The global gene synthesis market is segmented into product & services, application and end user. The product & services segment is classified as consumables, software and services. On the basis of application, the market is categorized into diagnostics, therapeutics, research & developmental activities and others. Based on the end user segment, the gene synthesis market is segmented into academic & research institutes, diagnostics laboratories, biotech & pharmaceutical companies, and others.

Buy the complete report @ http://bit.ly/2WWEtKS

Gene synthesis contribute in not only to improve the understanding of disease mechanisms, but it also provide novel diagnostic tools. The gene synthesis market is segmented into diagnostics, therapeutics, research & developmental activities and others. The methods based on synthetic biology enables in the development of novel strategies for the treatment of cancer, immune diseases metabolic disorders and infectious diseases and the production of cheap drugs. Moreover, the gene synthesis method is widely accepted for the cancer research studies, from initial studies of oncogenic signaling pathways, to the development of DNA vaccines that used in the prevention of cancer or therapeutic antibodies used for immuno-oncology treatments. Thus, the increasing adoption of the gene synthesis in various application is expected to drive the gene synthesis market over the forecast period.

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Web: https://www.theinsightpartners.com/

This release was published on openPR.